SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,758.40 -94.50
( -0.13%)

Global Indices

Nasdaq

52,511.77 524.74
(1.01%)

Dow Jones

7,731.20 19.47
(0.25%)

Hang Seng

63,869.15 -1,047.55
(-1.61%)

Nikkei 225

10,731.75 -32.94
(-0.31%)

Forex

USD-INR

94.90 0.12
(0.13%)

EUR-INR

106.44 -0.03
(-0.02%)

GBP-INR

126.38 0.12
(0.10%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

48.09

1160.13

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.05

Back

Shriram Finance consolidated net profit rises 59.89% in the June 2026 quarter

Jul 24,2026

Net profit of Shriram Finance rose 59.89% to Rs 3452.77 crore in the quarter ended June 2026 as against Rs 2159.40 crore during the previous quarter ended June 2025. Sales rose 15.96% to Rs 13229.11 crore in the quarter ended June 2026 as against Rs 11408.20 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	13229.11	11408.20	16
OPM %	75.55	74.28	-
PBDT	4808.51	3079.34	56
PBT	4625.72	2906.23	59
NP	3452.77	2159.40	60

73,758.40 -94.50 ( -0.13%)

52,511.77 524.74 (1.01%)

7,731.20 19.47 (0.25%)

63,869.15 -1,047.55 (-1.61%)

10,731.75 -32.94 (-0.31%)

94.90 0.12 (0.13%)

106.44 -0.03 (-0.02%)

126.38 0.12 (0.10%)

0.60 0.00 (-0.04%)